Akso Health Group (AHG) Stock Analysis

Q: What is the AHG stock price target?

Take-profit $2.41 (+7.6% upside). Prior stop was $2.08.

Q: Is AHG overvalued or undervalued?

Akso Health Group trades at a P/E of N/A (forward N/A). TrendMatrix value score: 5.0/10. Overall verdict: Sell.

Range Bound setup

SellModerate ConfidenceUpdated 2026-04-30

Healthcare · Medical Distribution

Sell if holding. Engine safety override at $2.22: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.2/10. Specifically: Below-average business quality.

$2.22+7.6% A.UpsideScore 4.2/10#5 of 5 Medical Distribution

Stop $2.08Target $2.41(resistance)A.R:R 0.0:1

Passes 5/6 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity no date, semi cycle peak clear). Suitability: aggressive.

Thesis

Rewards

No bull case signals

Risks

Quality below floor (1.7 < 4.0)

Key Metrics

P/E (TTM)—

P/E (Fwd)—

Mkt Cap$1.9B

EV/EBITDA-3930.7

Profit Mgn0.0%

ROE-68.3%

Rev Growth0.9%

Beta-0.93

DividendNone

Rating analysts—

Quality Signals

Piotroski F4/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Overall = weighted sum of the 10 dimension scores. Fundamentals (Value/Quality/Growth) carry 45%; market signals (Momentum/Sentiment/Insider/Peer) carry 40%; structure (Technical/Risk/Catalyst) carries 15%.

DimensionScoreWeightContribution

Value5.015%0.75

Quality1.715%0.26

Growth2.715%0.41

Momentum6.210%0.62

Sentiment5.910%0.59

Insider Activity5.010%0.50

Peer Rank2.510%0.25

Technical Setup5.75%0.29

Risk Profile6.15%0.30

Catalyst4.35%0.21

Overall (Σ contributions)4.18

Small float-rounding may cause last-digit differences between this sum and the displayed Overall.

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Roe

0.0

Roa

0.0

Gross Margin

0.0

Operating Margin

0.0

Net Margin

0.0

Fcf Quality

0.0

Piotroski F

4.4

Moat

5.0

Current Ratio

5.6

Cash-burning: FCF -1141% of revenueNo competitive moatQuality concerns

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Quality Rank

0.0

Growth Rank

0.0

Value Rank

5.0

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Revenue Growth

2.7

Low model confidence on this dimension (33%).

GatesA.R:R UPSIDE_EXHAUSTED (upside=0.0%)Momentum 6.2>=5.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARRange BoundSuitability: Aggressive

RSI

49 · Neutral

↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $1.87Resistance $2.46

Price Targets

A.Upside+8.6%

A.R:R0.0:1

Position Sizing

ConvictionNone

Suggested %0.5%

Max %1%

RegimeSteady

Risk Alerts

! Quality below floor (1.7 < 4.0)

Earnings

2/4 beats

Verdict History

reverse chrono — latest first

Loading history...

Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.

Frequently Asked Questions

Is AHG stock a buy right now?

Sell if holding. Engine safety override at $2.22: Quality below floor (1.7 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 4.2/10. Specifically: Below-average business quality. Chart setup: RSI 49 mid-range, Bollinger mid-band. Prior stop was $2.08. Score 4.2/10, moderate confidence.

What is the AHG stock price target?

Take-profit target: $2.41 (+7.6% upside). Prior stop was $2.08. Stop-loss: $2.08.

What are the risks of investing in AHG?

Quality below floor (1.7 < 4.0).

Is AHG overvalued or undervalued?

Akso Health Group trades at a P/E of N/A (forward N/A). TrendMatrix value score: 5.0/10. Verdict: Sell.

What does Akso Health Group do?Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's...

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.